// App-Quantinova.ai

10009 : Efficacy and safety of checkpoint blockade for treatment of advanced melanoma (mel) in patients (pts) age 80 and older (80+).

Researchers

Presenter

  • Claire Frances Friedman

Principal Investigators

  • Troy Z Horvat

  • Janna Minehart

  • Katherine Panageas

  • Margaret K. Callahan

  • Paul B. Chapman

  • Parisa Momtaz

  • Michael Andrew Postow

  • Alexander Noor Shoushtari

  • Jedd D. Wolchok

  • Stuart M. Lichtman

Medical Centers

  • Memorial Sloan Kettering Cancer Center, Port Washington, NY

  • New York University School of Medicine, New York, NY

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Melanoma

Biomarkers

  • N/A

Drug/Treatment

  • Pembrolizumab

  • Ipilimumab

  • Nivolumab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved